Cadwalader Takes Corporate Inversions to Another Level

, The Am Law Daily

   | 0 Comments

Cadwalader, Wickersham & Taft may have found a way to help more U.S. companies use corporate inversions to lower their tax bills. Salix Pharmaceuticals has retained the firm, as well as Covington & Burling and leading Irish shop A&L Goodbody, for its $2.7 billion acquisition of patents to gastrointestinal drugs owned by an Irish unit of Italy's Cosmo Pharmaceuticals.

This article has been archived, and is no longer available on this website.

View this content exclusively through LexisNexis® Here

Not a LexisNexis® Subscriber?

Subscribe Now

Why am I seeing this?

LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® customers will be able to access and use ALM's content by subscribing to the LexisNexis® services via lexis.com® and Nexis®. This includes content from The National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM's other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.

ALM's content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.

For questions call 1-877-256-2472 or contact us at customercare@alm.com

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202662691305

Thank you!

This article's comments will be reviewed.